Medical Devices

Diabetes Management Continuous Glucose Monitoring Product Safety Patient Safety Regulatory Compliance Manufacturing Cardiology Regulatory Approval Diagnostic Tests Cardiovascular Devices

Humacyte Reports 2025 Results, Cites Early Symvess Uptake and Near-Term Dialysis Readout

The update sets up a near-term dialysis trial readout that could clear the way for a 2026 filing.

Lucid Diagnostics Sets Q4 Record as VA Contract Validates Pricing and Eyes Medicare Policy

Co-Diagnostics Expands CoSara Territory to Four South Asian Countries

ITC Judge Says Apple Watch Redesign Doesn’t Infringe as Appeals Court Upholds Earlier Ban

ElectroCore Reports Record 2025 Sales, Sets CEO Transition and Targets 30% Growth for 2026

Humacyte Raises $20 Million in Direct Offering and Lands Saudi Symvess Purchase Pact

Embecta Strikes Deal to Acquire Owen Mumford for Up to £150 Million

Alcon and LENSAR End Merger Following FTC Opposition

Intuitive Surgical Takes Over Southern Europe Distribution After Closing Distributors Deal

Cooper Companies Tops Q1, Lifts EPS Outlook as Shares Slide on Asia-Pacific Caution

MiniMed Prices $560 Million IPO at $20 in Nasdaq Debut

Science Corp Raises $230 Million to Advance Retinal Implant Toward EU Launch

Aristotle Flags Guardant Health as Key Q4 Contributor on Strong Results, Acquisition News

Avanos Tops 2025 Guidance, Sets 2026 Outlook as It Reroutes Production

Medtronic's 48-Year Dividend Streak Anchors Plan to Spin Off Diabetes Unit

ICU Medical Closes FDA Warning Letter, Posts Mixed Q4 and Sets 2026 Targets

Tandem Diabetes Care Shifts to Pharmacy Pay-As-You-Go, Guides to Lower Near-Term Revenue

Zynex Admits Years-Long Fraud in DOJ Deal, Will Pay Up to $12.5 Million and Forfeit Nearly $100 Million

Beta Bionics Beats Q4 Estimates, Sets 2026 Guidance With Pharmacy-Channel Targets

Dexcom Posts Q4 Beat, Launches 15‑Day G7, Reaffirms 2026 Outlook